Indeed, flow cytometry detected substantially more OVA-specific CD8+ T cells in tumours from mice vaccinated with pErNP–OVA–CpG B than in tumours from control mice treated with PBS (Fig. 4f and Supplementary Figs. 18–21). This evidence concerns the gene CD8A and neoplasm.